Metals and cholesterol: Two sides of the same coin in Alzheimer's disease pathology

Frontiers in Aging Neuroscience

Volumn 6, Issue MAY, 2014, Pages

  Wong, Bruce X ^a   Hung, Ya Hui ^a   Bush, Ashley I ^a   Duce, James A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid precursor protein; A ; Cholesterol; Copper; Iron; Metals; Zinc

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN; ASPARTIC PROTEINASE; CHOLESTEROL; COPPER; DISINTEGRIN; GAMMA SECRETASE; IRON; IRON REGULATORY FACTOR; LIPOPROTEIN RECEPTOR; METALLOPROTEINASE; ZINC;

ALZHEIMER DISEASE; BINDING SITE; BRAIN TOXICITY; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; CYTOTOXICITY; DIETARY INTAKE; DOWN REGULATION; FOLLOW UP; HUMAN; IN VITRO STUDY; IRON INTAKE; IRON RESPONSIVE ELEMENT; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROMODULATION; NONHUMAN; PATHOGENESIS; PATHOLOGY; PROTEIN DEGRADATION; REVIEW; RISK FACTOR; UPREGULATION;

EID: 84901347296     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00091     Document Type: Review

References (264)

1. Acevedo, K. M., Hung, Y. H., Dalziel, A. H., Li, Q. X., Laughton, K., Wikhe, K., et al. (2011). Copper promotes the trafficking of the amyloid precursor protein. J. Biol. Chem. 286, 8252-8262. doi: 10.1074/jbc.M110.128512
2. Ali, F. E., Separovic, F., Barrow, C. J., Cherny, R. A., Fraser, F., Bush, A. I., et al. (2005). Methionine regulates copper/hydrogen peroxide oxidation products of Abeta. J. Pept. Sci. 11, 353-360. doi: 10.1002/psc.626
3. Angeletti, B., Waldron, K. J., Freeman, K. B., Bawagan, H., Hussain, I., Miller, C. C., et al. (2005). BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper. J. Biol. Chem. 280, 17930-17937. doi: 10.1074/jbc.M412034200
4. Area-Gomez, E., Del Carmen Lara Castillo, M., Tambini, M. D., Guardia-Laguarta, C., De Groof, A. J., Madra, M., et al. (2012). Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 31, 4106-4123. doi: 10.1038/emboj.2012.202
5. Arispe, N., and Doh, M. (2002). Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J. 16, 1526-1536. doi: 10.1096/fj.02-0829com
6. Armendariz, A. D., Gonzalez, M., Loguinov, A. V., and Vulpe, C. D. (2004). Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. Physiol. Genomics 20, 45-54. doi: 10.1152/physiolgenomics.00196.2003
7. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., et al. (1998). Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273, 12817-12826. doi: 10.1074/jbc.273.21.12817
8. Atwood, C. S., Perry, G., Zeng, H., Kato, Y., Jones, W. D., Ling, K. Q., et al. (2004). Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. Biochemistry 43, 560-568. doi: 10.1021/bi0358824
9. Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., et al. (2000). Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75, 1219-1233. doi: 10.1046/j.1471-4159.2000.0751219.x
10. Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, D., Delong, C., et al. (2009). Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29, 6771-6779. doi: 10.1523/JNEUROSCI.0887-09.2009
11. Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., et al. (1999). Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 96, 15233-15238. doi: 10.1073/pnas.96.26.15233
12. Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., et al. (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17, 263-264. doi: 10.1038/ng1197-263
13. Baltes, C., Princz-Kranz, F., Rudin, M., and Mueggler, T. (2011). Detecting amyloid-beta plaques in Alzheimer's disease. Methods Mol. Biol. 711, 511-533. doi: 10.1007/978-1-61737-992-5_26
14. Barnham, K. J., Haeffner, F., Ciccotosto, G. D., Curtain, C. C., Tew, D., Mavros, C., et al. (2004). Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid. FASEB J. 18, 1427-1429. doi: 10.1096/fj.04-1890fje
15. Barnham, K. J., Mckinstry, W. J., Multhaup, G., Galatis, D., Morton, C. J., Curtain, C. C., et al. (2003). Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. J. Biol. Chem. 278, 17401-17407. doi: 10.1074/jbc.M300629200
16. Barrett, P. J., Song, Y., Van Horn, W. D., Hustedt, E. J., Schafer, J. M., Hadziselimovic, A., et al. (2012). The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336, 1168-1171. doi: 10.1126/science.1219988
17. Bayer, T. A., Schafer, S., Simons, A., Kemmling, A., Kamer, T., Tepest, R., et al. (2003). Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 100, 14187-14192. doi: 10.1073/pnas.2332818100
18. Beel, A. J., Sakakura, M., Barrett, P. J., and Sanders, C. R. (2010). Direct binding of cholesterol to the amyloid precursor protein: an important interaction in lipid-Alzheimer's disease relationships? Biochim. Biophys. Acta 1801, 975-982. doi: 10.1016/j.bbalip.2010.03.008
19. Beffert, U., Aumont, N., Dea, D., Lussier-Cacan, S., Davignon, J., and Poirier, J. (1998). Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J. Neurochem. 70, 1458-1466. doi: 10.1046/j.1471-4159.1998.70041458.x
20. Beffert, U., Aumont, N., Dea, D., Lussier-Cacan, S., Davignon, J., and Poirier, J. (1999). Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures. Brain Res. Mol. Brain Res. 68, 181-185. doi: 10.1016/S0169-328X(99)00073-X
21. Bellingham, S. A., Ciccotosto, G. D., Needham, B. E., Fodero, L. R., White, A. R., Masters, C. L., et al. (2004a). Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts. J. Neurochem. 91, 423-428. doi: 10.1111/j.1471-4159.2004.02731.x
22. Bellingham, S. A., Lahiri, D. K., Maloney, B., La Fontaine, S., Multhaup, G., and Camakaris, J. (2004b). Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene. J. Biol. Chem. 279, 20378-20386. doi: 10.1074/jbc.M400805200
23. Bertram, L., Mcqueen, M. B., Mullin, K., Blacker, D., and Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23. doi: 10.1038/ng1934
24. Bertram, L., and Tanzi, R. E. (2005). The genetic epidemiology of neurodegenerative disease. J. Clin. Invest. 115, 1449-1457. doi: 10.1172/JCI24761
25. Biere, A. L., Ostaszewski, B., Zhao, H., Gillespie, S., Younkin, S. G., and Selkoe, D. J. (1995). Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing. Neurobiol. Dis. 2, 177-187. doi: 10.1006/nbdi.1995.0019.
26. Bjorkhem, I. (2013). Five decades with oxysterols. Biochimie 95, 448-454. doi: 10.1016/j.biochi.2012.02.029
27. Bjorkhem, I., Lutjohann, D., Diczfalusy, U., Stahle, L., Ahlborg, G., and Wahren, J. (1998). Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39, 1594-1600.
28. Blacker, M., Noe, M. C., Carty, T. J., Goodyer, C. G., and Leblanc, A. C. (2002). Effect of tumor necrosis factor-alpha converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons. J. Neurochem. 83, 1349-1357. doi: 10.1046/j.1471-4159.2002.01228.x
29. Bodovitz, S., and Klein, W. L. (1996). Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440. doi: 10.1074/jbc.271.8.4436
30. Borbon, I. A., and Erickson, R. P. (2011). Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's. J. Appl. Genet. 52, 213-218. doi: 10.1007/s13353-010-0021-1
31. Bouillot, C., Prochiantz, A., Rougon, G., and Allinquant, B. (1996). Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties. J. Biol. Chem. 271, 7640-7644. doi: 10.1074/jbc.271.13.7640
32. Brown, M. S., and Goldstein, J. L. (1999). A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. U.S.A. 96, 11041-11048. doi: 10.1073/pnas.96.20.11041
33. Bryleva, E. Y., Rogers, M. A., Chang, C. C., Buen, F., Harris, B. T., Rousselet, E., et al. (2010). ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proc. Natl. Acad. Sci. U.S.A. 107, 3081-3086. doi: 10.1073/pnas.0913828107
34. Buckley, C. A., Rouhani, F. N., Kaler, M., Adamik, B., Hawari, F. I., and Levine, S. J. (2005). Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L1132-L1138. doi: 10.1152/ajplung.00429.2004
35. Bulloj, A., Leal, M. C., Surace, E. I., Zhang, X., Xu, H., Ledesma, M. D., et al. (2008). Detergent resistant membrane-associated IDE in brain tissue and cultured cells: relevance to Abeta and insulin degradation. Mol. Neurodegener. 3, 22. doi: 10.1186/1750-1326-3-22
36. Burns, M., Gaynor, K., Olm, V., Mercken, M., Lafrancois, J., Wang, L., et al. (2003). Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo. J. Neurosci. 23, 5645-5649.
37. Bush, A. I., Multhaup, G., Moir, R. D., Williamson, T. G., Small, D. H., Rumble, B., et al. (1993). A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268, 16109-16112.
38. Bush, A. I., Multhaup, G., Moir, R. D., Williamson, T. G., Small, D. H., Rumble, B., et al. (1993). A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268, 16109-16112.
39. Bush, A. I., Pettingell, W. H. Jr., De Paradis, M., Tanzi, R. E., and Wasco, W. (1994a). The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. J. Biol. Chem. 269, 26618-26621.
40. Bush, A. I., Pettingell, W. H. Jr., Paradis, M. D., and Tanzi, R. E. (1994b). Modulation of A beta adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269, 12152-12158.
41. Bush, A. I., Pettingell, W. H., Multhaup, G., d Paradis, M., Vonsattel, J. P., Gusella, J. F., et al. (1994c). Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265, 1464-1467. doi: 10.1126/science.8073293
42. Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., et al. (1998). Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767. doi: 10.1074/jbc.273.43.27765
43. Caccamo, A., Oddo, S., Sugarman, M. C., Akbari, Y., and Laferla, F. M. (2005). Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol. Aging 26, 645-654. doi: 10.1016/j.neurobiolaging.2004.06.013
44. Cao, D., Fukuchi, K., Wan, H., Kim, H., and Li, L. (2006). Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol. Aging 27, 1632-1643. doi: 10.1016/j.neurobiolaging.2005.09.011
45. Carson, J. A., and Turner, A. J. (2002). Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J. Neurochem. 81, 1-8. doi: 10.1046/j.1471-4159.2002.00855.x
46. Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., Demattos, R. B., Patterson, B. W., et al. (2011). Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci. Transl. Med. 3, 89ra57. doi: 10.1126/scitranslmed.3002156
47. Cedazo-Minguez, A., Wiehager, B., Winblad, B., Huttinger, M., and Cowburn, R. F. (2001). Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts. Neurochem. Int. 38, 615-625. doi: 10.1016/S0197-0186(00)00128-5 CrossRef Full Text Chen, J. H., Lin, K. P., and Chen, Y. C. (2009). Risk factors for dementia. J. Formos. Med. Assoc. 108, 754-764. doi: 10.1016/S0929-6646(09)60402-2
48. Cho, H. H., Cahill, C. M., Vanderburg, C. R., Scherzer, C. R., Wang, B., Huang, X., et al. (2010). Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J. Biol. Chem. 285, 31217-31232. doi: 10.1074/jbc.M110.149161
49. Choo-Smith, L. P., Garzon-Rodriguez, W., Glabe, C. G., and Surewicz, W. K. (1997). Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272, 22987-22990. doi: 10.1074/jbc.272.37.22987
50. Ciccotosto, G. D., Tew, D., Curtain, C. C., Smith, D., Carrington, D., Masters, C. L., et al. (2004). Enhanced toxicity and cellular binding of a modified amyloid beta peptide with a methionine to valine substitution. J. Biol. Chem. 279, 42528-42534. doi: 10.1074/jbc.M406465200
51. Cirrito, J. R., Deane, R., Fagan, A. M., Spinner, M. L., Parsadanian, M., Finn, M. B., et al. (2005). P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J. Clin. Invest. 115, 3285-3290. doi: 10.1172/JCI25247
52. Ciuculescu, E. D., Mekmouche, Y., and Faller, P. (2005). Metal-binding properties of the peptide APP170-188: a model of the ZnII-binding site of amyloid precursor protein (APP). Chemistry 11, 903-909. doi: 10.1002/chem.200400786
53. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., et al. (2005). Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84. doi: 10.1038/nn1372
54. Cole, G. M., and Ard, M. D. (2000). Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein. Microsc. Res. Tech. 50, 316-324. doi: 10.1002/1097-0029(20000815)50:4< 316::AID-JEMT11> 3.0.CO;2-E
55. Cole, T. B., Wenzel, H. J., Kafer, K. E., Schwartzkroin, P. A., and Palmiter, R. D. (1999). Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc. Natl. Acad. Sci. U.S.A. 96, 1716-1721. doi: 10.1073/pnas.96.4.1716
56. Collingwood, J. F., Mikhaylova, A., Davidson, M., Batich, C., Streit, W. J., Terry, J., et al. (2005). In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J. Alzheimers Dis. 7, 267-272.
57. Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., and Mufson, E. J. (1992). Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 31, 327-335. doi: 10.1002/jnr.490310214
58. Coon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., et al. (2007). A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J. Clin. Psychiatry 68, 613-618. doi: 10.4088/JCP.v68n0419
59. Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y., Karlo, J. C., Zinn, A. E., et al. (2012). ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335, 1503-1506. doi: 10.1126/science.1217697
60. Crameri, A., Biondi, E., Kuehnle, K., Lutjohann, D., Thelen, K. M., Perga, S., et al. (2006). The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta
61. Cross, J. B., Duca, J. S., Kaminski, J. J., and Madison, V. S. (2002). The active site of a zinc-dependent metalloproteinase influences the computed pK(a) of ligands coordinated to the catalytic zinc ion. J. Am. Chem. Soc. 124, 11004-11007. doi: 10.1021/ja0201810
62. Crouch, P. J., Tew, D. J., Du, T., Nguyen, D. N., Caragounis, A., Filiz, G., et al. (2009). Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation. J. Neurochem. 108, 1198-1207. doi: 10.1111/j.1471-4159.2009.05870.x
63. Cummings, J. L. (2004). Alzheimer's disease. N. Engl. J. Med. 351, 56-67. doi: 10.1056/NEJMra040223 CrossRef Full Text Curtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., et al. (2001). Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276, 20466-20473. doi: 10.1074/jbc.M100175200
64. Dahlgren, K. N., Manelli, A. M., Stine, W. B. Jr., Baker, L. K., Krafft, G. A., et al. (2002). Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053. doi: 10.1074/jbc.M201750200
65. Dahms, S. O., Konnig, I., Roeser, D., Guhrs, K. H., Mayer, M. C., Kaden, D., et al. (2012). Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain. J. Mol. Biol. 416, 438-452. doi: 10.1016/j.jmb.2011.12.057
66. Danielsson, J., Pierattelli, R., Banci, L., and Graslund, A. (2007). High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide. FEBS J. 274, 46-59. doi: 10.1111/j.1742-4658.2006.05563.x
67. Davis, C. D., Milne, D. B., and Nielsen, F. H. (2000). Changes in dietary zinc and copper affect zinc-status indicators of postmenopausal women, notably, extracellular superoxide dismutase and amyloid precursor proteins. Am. J. Clin. Nutr. 71, 781-788.
68. Davis, W. Jr. (2008). The cholesterol transport inhibitor U18666a regulates amyloid precursor protein metabolism and trafficking in N2aAPP "Swedish" cells. Curr. Alzheimer Res. 5, 448-456. doi: 10.2174/156720508785908900
69. Delacourte, A., and Defossez, A. (1986). Alzheimer's disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J. Neurol. Sci. 76, 173-186. doi: 10.1016/0022-510X(86)90167-X
70. Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., et al. (2005). The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191-200. doi: 10.1016/j.cmet.2005.01.003
71. Duce, J. A., and Bush, A. I. (2010). Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Prog. Neurobiol. 92, 1-18. doi: 10.1016/j.pneurobio.2010.04.003
72. Duce, J. A., Tsatsanis, A., Cater, M. A., James, S. A., Robb, E., Wikhe, K., et al. (2010). Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867. doi: 10.1016/j.cell.2010.08.014
73. Eckert, A., Hauptmann, S., Scherping, I., Meinhardt, J., Rhein, V., Drose, S., et al. (2008). Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice. J. Mol. Med. (Berl.) 86, 1255-1267. doi: 10.1007/s00109-008-0391-6
74. Eckert, G. P., Vardanian, L., Rebeck, G. W., and Burns, M. P. (2007). Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317. Neurosci. Lett. 423, 47-52. doi: 10.1016/j.neulet.2007.05.063
75. Eckert, G. P., Wood, W. G., and Muller, W. E. (2010). Lipid membranes and beta-amyloid: a harmful connection. Curr. Protein Pept. Sci 11, 319-325. doi: 10.2174/138920310791330668
76. Edbauer, D., Winkler, E., Regula, J. T., Pesold, B., Steiner, H., and Haass, C. (2003). Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486-488. doi: 10.1038/ncb960
77. Ehehalt, R., Keller, P., Haass, C., Thiele, C., and Simons, K. (2003). Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113-123. doi: 10.1083/jcb.200207113
78. Faller, P., and Hureau, C. (2009). Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. Dalton Trans. 1080-1094. doi: 10.1039/b813398k
79. Fan, J., Donkin, J., and Wellington, C. (2009). Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Biofactors 35, 239-248. doi: 10.1002/biof.37
80. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349-1356. doi: 10.1002/biof.37
81. Fenton, H. J. H. (1894). Oxidation of tartaric acid in presence of iron. J. Chem. Soc. Trans. 65, 899-911. doi: 10.1039/ct8946500899 CrossRef Full Text Ferrera, P., Mercado-Gomez, O., Silva-Aguilar, M., Valverde, M., and Arias, C. (2008). Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress. Neurochem. Res. 33, 1509-1517. doi: 10.1007/s11064-008-9623-y
82. Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H., and Austen, B. M. (1999). The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport 10, 1699-1705. doi: 10.1007/s11064-008-9623-y
83. Friedlich, A. L., Lee, J. Y., Van Groen, T., Cherny, R. A., Volitakis, I., Cole, T. B., et al. (2004). Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. J. Neurosci. 24, 3453-3459. doi: 10.1523/JNEUROSCI.0297-04.2004
84. Gaggelli, E., Grzonka, Z., Kozlowski, H., Migliorini, C., Molteni, E., Valensin, D., et al. (2008). Structural features of the Cu(II) complex with the rat Abeta(1-28) fragment. Chem. Commun. (Camb.) 341-343. doi: 10.1523/JNEUROSCI.0297-04.2004
85. Ganz, T. (2005). Cellular iron: ferroportin is the only way out. Cell Metab. 1, 155-157. doi: 10.1016/j.cmet.2005.02.005
86. Garai, K., Sengupta, P., Sahoo, B., and Maiti, S. (2006). Selective destabilization of soluble amyloid beta oligomers by divalent metal ions. Biochem. Biophys. Res. Commun. 345, 210-215. doi: 10.1016/j.bbrc.2006.04.056
87. Ghribi, O., Golovko, M. Y., Larsen, B., Schrag, M., and Murphy, E. J. (2006). Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J. Neurochem. 99, 438-449. doi: 10.1111/j.1471-4159.2006.04079.x
88. Glenner, G. G., and Wong, C. W. (1984a). Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135. doi: 10.1016/0006-291X(84)91209-9
89. Glenner, G. G., and Wong, C. W. (1984b). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890. doi: 10.1016/S0006-291X(84)80190-4
90. Gong, J. S., Morita, S. Y., Kobayashi, M., Handa, T., Fujita, S. C., Yanagisawa, K., et al. (2007). Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons. Mol. Neurodegener. 2, 9. doi: 10.1186/1750-1326-2-9
91. Goodman, L. (1953). Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 118, 97-130. doi: 10.1097/00005053-195308000-00001 CrossRef Full Text Greenough, M. A., Volitakis, I., Li, Q. X., Laughton, K., Evin, G., Ho, M., et al. (2011). Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper/zinc superoxide dismutase activity. J. Biol. Chem. 286, 9776-9786. doi: 10.1074/jbc.M110.163964
92. Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., et al. (1992). Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325. doi: 10.1038/359322a0
93. Haass, C., and Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112. doi: 10.1038/nrm2101
94. Haber, F., and Weiss, J. (1934). The catalytic decomposition of hydrogen peroxide by iron salts. Proc. R. Soc. Lond. A. Math. Phys. Sci. 147, 332-351. doi: 10.1098/rspa.1934.0221 CrossRef Full Text Haeffner, F., Smith, D. G., Barnham, K. J., and Bush, A. I. (2005). Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry. J. Inorg. Biochem. 99, 2403-2422. doi: 10.1016/j.jinorgbio.2005.09.011
95. Hama, E., Shirotani, K., Iwata, N., and Saido, T. C. (2004). Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. J. Biol. Chem. 279, 30259-30264. doi: 10.1074/jbc.M401891200
96. Hayashi, H., Igbavboa, U., Hamanaka, H., Kobayashi, M., Fujita, S. C., Wood, W. G., et al. (2002). Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice. Neuroreport 13, 383-386. doi: 10.1097/00001756-200203250-00004
97. Hesse, L., Beher, D., Masters, C. L., and Multhaup, G. (1994). The beta A4 amyloid precursor protein binding to copper. FEBS Lett. 349, 109-116. doi: 10.1016/0014-5793(94)00658-X
98. Himes, R. A., Park, G. Y., Siluvai, G. S., Blackburn, N. J., and Karlin, K. D. (2008). Structural studies of copper(I) complexes of amyloid-beta peptide fragments: formation of two-coordinate bis(histidine) complexes. Angew. Chem. Int. Ed. Engl. 47, 9084-9087. doi: 10.1002/anie.200803908
99. Hirsch-Reinshagen, V., Maia, L. F., Burgess, B. L., Blain, J. F., Naus, K. E., Mcisaac, S. A., et al. (2005). The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J. Biol. Chem. 280, 43243-43256. doi: 10.1074/jbc.M508781200
100. Hoke, D. E., Tan, J. L., Ilaya, N. T., Culvenor, J. G., Smith, S. J., White, A. R., et al. (2005). In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc. FEBS J. 272, 5544-5557. doi: 10.1111/j.1742-4658.2005.04950.x
101. Holmes, C. (2002). Genotype and phenotype in Alzheimer's disease. Br. J. Psychiatry 180, 131-134. doi: 10.1192/bjp.180.2.131
102. Holtzman, D. M., Fagan, A. M., Mackey, B., Tenkova, T., Sartorius, L., Paul, S. M., et al. (2000). Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol. 47, 739-747. doi: 10.1002/1531-8249(200006)47:6< 739::AID-ANA6> 3.0.CO;2-8
103. Huang, L., Kirschke, C. P., and Gitschier, J. (2002). Functional characterization of a novel mammalian zinc transporter, ZnT6. J. Biol. Chem. 277, 26389-26395. doi: 10.1074/jbc.M200462200
104. Huang, X., Atwood, C. S., Moir, R. D., Hartshorn, M. A., Tanzi, R. E., and Bush, A. I. (2004). Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J. Biol. Inorg. Chem. 9, 954-960. doi: 10.1007/s00775-004-0602-8 CrossRef Full Text Huang, X., Atwood, C. S., Moir, R. D., Hartshorn, M. A., Vonsattel, J. P., Tanzi, R. E., et al. (1997). Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J. Biol. Chem. 272, 26464-26470. doi: 10.1074/jbc.272.42.26464
105. Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D., Hanson, G. R., et al. (1999). Cu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274, 37111-37116. doi: 10.1074/jbc.274.52.37111
106. Hung, Y. H., Bush, A. I., and La Fontaine, S. (2013). Links between copper and cholesterol in Alzheimer's disease. Front. Physiol. 4:111. doi: 10.3389/fphys.2013.00111
107. Hung, Y. H., Faux, N. G., Killilea, D. W., Yanjanin, N., Firnkes, S., Volitakis, I., et al. (2014). Altered transition metal homeostasis in Niemann-Pick disease, type C1. Metallomics 6, 542-553. doi: 10.1039/c3mt00308f
108. Hung, Y. H., Robb, E. L., Volitakis, I., Ho, M., Evin, G., Li, Q. X., et al. (2009). Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease. J. Biol. Chem. 284, 21899-21907. doi: 10.1074/jbc.M109.019521
109. Hur, J. Y., Welander, H., Behbahani, H., Aoki, M., Franberg, J., Winblad, B., et al. (2008). Active gamma-secretase is localized to detergent-resistant membranes in human brain. FEBS J. 275, 1174-1187. doi: 10.1111/j.1742-4658.2008.06278.x
110. Hureau, C., and Faller, P. (2009). Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease. Biochimie 91, 1212-1217. doi: 10.1016/j.biochi.2009.03.013
111. Irizarry, M. C., Cheung, B. S., Rebeck, G. W., Paul, S. M., Bales, K. R., and Hyman, B. T. (2000). Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice. Acta Neuropathol. 100, 451-458. doi: 10.1007/s004010000263
112. Irizarry, M. C., Deng, A., Lleo, A., Berezovska, O., Von Arnim, C. A., Martin-Rehrmann, M., et al. (2004). Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein. J. Neurochem. 90, 1132-1143. doi: 10.1111/j.1471-4159.2004.02581.x
113. Iuliano, L. (2011). Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem. Phys. Lipids 164, 457-468. doi: 10.1016/j.chemphyslip.2011.06.006
114. Iwatsubo, T. (2004). The gamma-secretase complex: machinery for intramembrane proteolysis. Curr. Opin. Neurobiol 14, 379-383. doi: 10.1016/j.conb.2004.05.010
115. Janssen, J. C., Beck, J. A., Campbell, T. A., Dickinson, A., Fox, N. C., Harvey, R. J., et al. (2003). Early onset familial Alzheimer's disease: mutation frequency in 31 families. Neurology 60, 235-239. doi: 10.1212/01.WNL.0000042088.22694.E3
116. Jiao, Y., and Yang, P. (2007). Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation. J. Phys. Chem. B 111, 7646-7655. doi: 10.1021/jp0673359.
117. Jin, L. W., Shie, F. S., Maezawa, I., Vincent, I., and Bird, T. (2004). Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am. J. Pathol. 164, 975-985. doi: 10.1016/S0002-9440(10)63185-9
118. Kaden, D., Munter, L. M., Joshi, M., Treiber, C., Weise, C., Bethge, T., et al. (2008). Homophilic interactions of the amyloid precursor protein (APP) ectodomain are regulated by the loop region and affect beta-secretase cleavage of APP. J. Biol. Chem. 283, 7271-7279. doi: 10.1074/jbc.M708046200
119. Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. (2002). Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41, 7385-7390. doi: 10.1021/bi0255874
120. Kalvodova, L., Kahya, N., Schwille, P., Ehehalt, R., Verkade, P., Drechsel, D., et al. (2005). Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J. Biol. Chem. 280, 36815-36823. doi: 10.1074/jbc.M504484200
121. Karr, J. W., and Szalai, V. A. (2008). Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide. Biochemistry 47, 5006-5016. doi: 10.1021/bi702423h
122. Kayed, R., Head, E., Thompson, J. L., Mcintire, T. M., Milton, S. C., Cotman, C. W., et al. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. doi: 10.1126/science.1079469
123. Kelleher, S. L., and Lonnerdal, B. (2002). Zinc transporters in the rat mammary gland respond to marginal zinc and vitamin A intakes during lactation. J. Nutr. 132, 3280-3285.
124. Kienlen-Campard, P., Tasiaux, B., Van Hees, J., Li, M., Huysseune, S., Sato, T., et al. (2008). Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs. J. Biol. Chem. 283, 7733-7744. doi: 10.1074/jbc.M707142200
125. Kim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., et al. (2009). Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance. Neuron 64, 632-644. doi: 10.1016/j.neuron.2009.11.013
126. Kim, S., Jeon, T. J., Oberai, A., Yang, D., Schmidt, J. J., and Bowie, J. U. (2005). Transmembrane glycine zippers: physiological and pathological roles in membrane proteins. Proc. Natl. Acad. Sci. U.S.A. 102, 14278-14283. doi: 10.1073/pnas.0501234102
127. Kim, S. I., Yi, J. S., and Ko, Y. G. (2006). Amyloid beta oligomerization is induced by brain lipid rafts. J. Cell. Biochem. 99, 878-889. doi: 10.1002/jcb.20978
128. Kodam, A., Maulik, M., Peake, K., Amritraj, A., Vetrivel, K. S., Thinakaran, G., et al. (2010). Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains. Glia 58, 1267-1281. doi: 10.1002/glia.21001
129. Kojro, E., Gimpl, G., Lammich, S., Marz, W., and Fahrenholz, F. (2001). Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. U.S.A. 98, 5815-5820. doi: 10.1073/pnas.081612998
130. Koldamova, R., Staufenbiel, M., and Lefterov, I. (2005). Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem. 280, 43224-43235. doi: 10.1074/jbc.M504513200
131. Kosicek, M., Malnar, M., Goate, A., and Hecimovic, S. (2010). Cholesterol accumulation in Niemann-Pick type C (NPC) model cells causes a shift in APP localization to lipid rafts. Biochem. Biophys. Res. Commun. 393, 404-409. doi: 10.1016/j.bbrc.2010.02.007
132. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986). Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83, 4044-4048. doi: 10.1073/pnas.83.11.4044
133. Kuhn, P. H., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., et al. (2010). ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032. doi: 10.1038/emboj.2010.167
134. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., et al. (1999). Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A. 96, 3922-3927. doi: 10.1073/pnas.96.7.3922
135. Ledesma, M. D., Abad-Rodriguez, J., Galvan, C., Biondi, E., Navarro, P., Delacourte, A., et al. (2003). Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep. 4, 1190-1196. doi: 10.1038/sj.embor.7400021
136. Lee, J. Y., Cole, T. B., Palmiter, R. D., Suh, S. W., and Koh, J. Y. (2002). Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 99, 7705-7710. doi: 10.1073/pnas.092034699
137. Lee, S. J., Liyanage, U., Bickel, P. E., Xia, W., Lansbury, P. T. Jr., and Kosik, K. S. (1998). A detergent-insoluble membrane compartment contains A beta in vivo. Nat. Med. 4, 730-734. doi: 10.1038/nm0698-730
138. Lee, V. M., Balin, B. J., Otvos, L. Jr., and Trojanowski, J. Q. (1991). A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251, 675-678. doi: 10.1126/science.1899488
139. Lei, P., Ayton, S., Finkelstein, D. I., Spoerri, L., Ciccotosto, G. D., Wright, D. K., et al. (2012). Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 18, 291-295. doi: 10.1038/nm.2613
140. Lesne, S., Kotilinek, L., and Ashe, K. H. (2008). Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience 151, 745-749. doi: 10.1016/j.neuroscience.2007.10.054
141. Lichtenthaler, S. F. (2011). alpha-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential. J. Neurochem. 116, 10-21. doi: 10.1111/j.1471-4159.2010.07081.x
142. Lin, M. S., Chen, L. Y., Wang, S. S., Chang, Y., and Chen, W. Y. (2008). Examining the levels of ganglioside and cholesterol in cell membrane on attenuation the cytotoxicity of beta-amyloid peptide. Colloids Surf. B Biointerfaces 65, 172-177. doi: 10.1016/j.colsurfb.2008.03.012
143. Lind, S. E., Mcdonagh, J. R., and Smith, C. J. (1993). Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate. Blood 82, 1522-1531.
144. Ling, Y., Morgan, K., and Kalsheker, N. (2003). Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int. J. Biochem. Cell Biol.
145. Linkous, D. H., Adlard, P. A., Wanschura, P. B., Conko, K. M., and Flinn, J. M. (2009). The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice. J. Alzheimers. Dis. 18, 565-579. doi: 10.3233/JAD-2009-1162
146. Linkous, D. H., Flinn, J. M., Koh, J. Y., Lanzirotti, A., Bertsch, P. M., Jones, B. F., et al. (2008). Evidence that the ZNT3 protein controls the total amount of elemental zinc in synaptic vesicles. J. Histochem. Cytochem. 56, 3-6. doi: 10.1369/jhc.6A7035.2007
147. Liu, B., Moloney, A., Meehan, S., Morris, K., Thomas, S. E., Serpell, L. C., et al. (2011). Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J. Biol. Chem. 286, 4248-4256. doi: 10.1074/jbc.M110.158980
148. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998). Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52. doi: 10.1016/S0022-510X(98)00092-6
149. Lovell, M. A., Smith, J. L., Xiong, S., and Markesbery, W. R. (2005). Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotox. Res. 7, 265-271. doi: 10.1007/BF03033884
150. Lund, E. G., Guileyardo, J. M., and Russell, D. W. (1999). cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U.S.A. 96, 7238-7243. doi: 10.1073/pnas.96.13.7238
151. Lutjohann, D., and von Bergmann, K. (2003). 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. Pharmacopsychiatry 36(Suppl. 2), S102-S106. doi: 10.1055/s-2003-43053
152. Mainous, A. G. III, Eschenbach, S. L., Wells, B. J., Everett, C. J., and Gill, J. M. (2005). Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort. Fam. Med. 37, 36-42.
153. Malnar, M., Kosicek, M., Lisica, A., Posavec, M., Krolo, A., Njavro, J., et al. (2012). Cholesterol-depletion corrects APP and BACE1 misstrafficking in NPC1-deficient cells. Biochim. Biophys. Acta 1822, 1270-1283. doi: 10.1016/j.bbadis.2012.04.002
154. Malnar, M., Kosicek, M., Mitterreiter, S., Omerbasic, D., Lichtenthaler, S. F., Goate, A., et al. (2010). Niemann-Pick type C cells show cholesterol dependent decrease of APP expression at the cell surface and its increased processing through the beta-secretase pathway. Biochim. Biophys. Acta 1802, 682-691. doi: 10.1016/j.bbadis.2010.05.006
155. Mantyh, P. W., Ghilardi, J. R., Rogers, S., Demaster, E., Allen, C. J., Stimson, E. R., et al. (1993). Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61, 1171-1174. doi: 10.1111/j.1471-4159.1993.tb03639.x
156. Marquer, C., Devauges, V., Cossec, J. C., Liot, G., Lecart, S., Saudou, F., et al. (2011). Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J. 25, 1295-1305. doi: 10.1096/fj.10-168633
157. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., Mcdonald, B. L., and Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249. doi: 10.1073/pnas.82.12.4245
158. Matsuzaki, K., Kato, K., and Yanagisawa, K. (2010). Abeta polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta 1801, 868-877. doi: 10.1016/j.bbalip.2010.01.008
159. Maulik, M., Westaway, D., Jhamandas, J. H., and Kar, S. (2013). Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis. Mol. Neurobiol. 47, 37-63. doi: 10.1007/s12035-012-8337-y
160. Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., et al. (2002). Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277, 44670-44676. doi: 10.1074/jbc.M204379200
161. Michikawa, M., Fan, Q. W., Isobe, I., and Yanagisawa, K. (2000). Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J. Neurochem. 74, 1008-1016. doi: 10.1046/j.1471-4159.2000.0741008.x
162. Miller, L. M., Wang, Q., Telivala, T. P., Smith, R. J., Lanzirotti, A., and Miklossy, J. (2006). Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 155, 30-37. doi: 10.1016/j.jsb.2005.09.004
163. Miyashita, N., Straub, J. E., Thirumalai, D., and Sugita, Y. (2009). Transmembrane structures of amyloid precursor protein dimer predicted by replica-exchange molecular dynamics simulations. J. Am. Chem. Soc. 131, 3438-3439. doi: 10.1021/ja809227c
164. Miyata, M., and Smith, J. D. (1996). Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14, 55-61. doi: 10.1038/ng0996-55
165. Moir, R. D., Atwood, C. S., Romano, D. M., Laurans, M. H., Huang, X., Bush, A. I., et al. (1999). Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations. Biochemistry 38, 4595-4603. doi: 10.1021/bi982437d
166. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Aggarwal, N., et al. (2003). Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60, 194-200. doi: 10.1001/archneur.60.2.194
167. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., and Wilson, R. S. (2004). Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 62, 1573-1579. doi: 10.1212/01.WNL.0000123250.82849.B6
168. Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., Schneider, J. A., Wilson, R. S., et al. (2006). Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch. Neurol. 63, 1085-1088. doi: 10.1001/archneur.63.8.1085
169. Muller-Spahn, F., and Hock, C. (1999). Risk factors and differential diagnosis of Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 249(Suppl. 3), 37-42. doi: 10.1007/PL00014172
170. Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., et al. (1996). The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271, 1406-1409. doi: 10.1126/science.271.5254.1406
171. Munter, L. M., Voigt, P., Harmeier, A., Kaden, D., Gottschalk, K. E., Weise, C., et al. (2007). GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. EMBO J. 26, 1702-1712. doi: 10.1038/sj.emboj.7601616
172. Murray, I. V., Sindoni, M. E., and Axelsen, P. H. (2005). Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochemistry 44, 12606-12613. doi: 10.1021/bi050926p
173. Needham, B. E., Ciccotosto, G. D., and Cappai, R. (2014). Combined deletions of amyloid precursor protein and amyloid precursor-like protein 2 reveal different effects on mouse brain metal homeostasis. Metallomics 6, 598-603. doi: 10.1039/c3mt00358b
174. Nelson, T. J., and Alkon, D. L. (2005). Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. J. Biol. Chem. 280, 7377-7387. doi: 10.1074/jbc.M409071200
175. Noda, Y., Asada, M., Kubota, M., Maesako, M., Watanabe, K., Uemura, M., et al. (2013). Copper enhances APP dimerization and promotes Abeta production. Neurosci. Lett. 547, 10-15. doi: 10.1016/j.neulet.2013.04.057
176. Okada, T., Ikeda, K., Wakabayashi, M., Ogawa, M., and Matsuzaki, K. (2008). Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils. J. Mol. Biol. 382, 1066-1074. doi: 10.1016/j.jmb.2008.07.072
177. Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., et al. (2002). Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J. Biol. Chem. 277, 40302-40308. doi: 10.1074/jbc.M206428200
178. Osenkowski, P., Ye, W., Wang, R., Wolfe, M. S., and Selkoe, D. J. (2008). Direct and potent regulation of gamma-secretase by its lipid microenvironment. J. Biol. Chem. 283, 22529-22540. doi: 10.1074/jbc.M801925200
179. Panchal, M., Loeper, J., Cossec, J. C., Perruchini, C., Lazar, A., Pompon, D., et al. (2010). Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry. J. Lipid Res. 51, 598-605. doi: 10.1194/jlr.M001859
180. Park, I. H., Jung, M. W., Mori, H., and Mook-Jung, I. (2001). Zinc enhances synthesis of presenilin 1 in mouse primary cortical culture. Biochem. Biophys. Res. Commun. 285, 680-688. doi: 10.1006/bbrc.2001.5243
181. Parkin, E. T., Turner, A. J., and Hooper, N. M. (1999). Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein. Biochem. J. 344(Pt 1), 23-30. doi: 10.1042/0264-6021:3440023
182. Perrone, L., Mothes, E., Vignes, M., Mockel, A., Figueroa, C., Miquel, M. C., et al. (2010). Copper transfer from Cu-Abeta to human serum albumin inhibits aggregation, radical production and reduces Abeta toxicity. Chembiochem 11, 110-118. doi: 10.1002/cbic.200900474
183. Phinney, A. L., Drisaldi, B., Schmidt, S. D., Lugowski, S., Coronado, V., Liang, Y., et al. (2003). In vivo reduction of amyloid-beta by a mutant copper transporter. Proc. Natl. Acad. Sci. U.S.A. 100, 14193-14198. doi: 10.1073/pnas.2332851100
184. Pierrot, N., Tyteca, D., D'Auria, L., Dewachter, I., Gailly, P., Hendrickx, A., et al. (2013). Amyloid precursor protein controls cholesterol turnover needed for neuronal activity. EMBO Mol. Med. 5, 608-625. doi: 10.1002/emmm.201202215
185. Poirier, J. (2003). Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol. Med. 9, 94-101. doi: 10.1016/S1471-4914(03)00007-8
186. Poirier, J., Baccichet, A., Dea, D., and Gauthier, S. (1993). Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55, 81-90. doi: 10.1016/0306-4522(93)90456-P
187. Puglielli, L., Friedlich, A. L., Setchell, K. D., Nagano, S., Opazo, C., Cherny, R. A., et al. (2005). Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. J. Clin. Invest. 115, 2556-2563. doi: 10.1172/JCI23610
188. Ramstedt, B., and Slotte, J. P. (2006). Sphingolipids and the formation of sterol-enriched ordered membrane domains. Biochim. Biophys. Acta 1758, 1945-1956. doi: 10.1016/j.bbamem.2006.05.020
189. Raux, G., Guyant-Marechal, L., Martin, C., Bou, J., Penet, C., Brice, A., et al. (2005). Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J. Med. Genet. 42, 793-795. doi: 10.1136/jmg.2005.033456
190. Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., et al. (2009). Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 106, 6820-6825. doi: 10.1073/pnas.0900345106
191. Riddell, D. R., Zhou, H., Comery, T. A., Kouranova, E., Lo, C. F., Warwick, H. K., et al. (2007). The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol. Cell. Neurosci. 34, 621-628. doi: 10.1016/j.mcn.2007.01.011
192. Rogers, J. T., Randall, J. D., Cahill, C. M., Eder, P. S., Huang, X., Gunshin, H., et al. (2002). An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 277, 45518-45528. doi: 10.1074/jbc.M207435200 CrossRef Full Text Roychaudhuri, R., Yang, M., Hoshi, M. M., and Teplow, D. B. (2009). Amyloid beta-protein assembly and Alzheimer disease. J. Biol. Chem. 284, 4749-4753. doi: 10.1074/jbc.R800036200 CrossRef Full Text Rozga, M., Protas, A. M., Jablonowska, A., Dadlez, M., and Bal, W. (2009). The Cu(II) complex of Abeta40 peptide in ammonium acetate solutions. Evidence for ternary species formation. Chem. Commun. (Camb.) 1374-1376. doi: 10.1039/b819616h
193. Runz, H., Rietdorf, J., Tomic, I., De Bernard, M., Beyreuther, K., Pepperkok, R., et al. (2002). Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J. Neurosci. 22, 1679-1689.
194. Sato, K., Tanabe, C., Yonemura, Y., Watahiki, H., Zhao, Y., Yagishita, S., et al. (2012). Localization of mature neprilysin in lipid rafts. J. Neurosci. Res. 90, 870-877. doi: 10.1002/jnr.22796
195. Sato, T., Tang, T. C., Reubins, G., Fei, J. Z., Fujimoto, T., Kienlen-Campard, P., et al. (2009). A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis. Proc. Natl. Acad. Sci. U.S.A. 106, 1421-1426. doi: 10.1073/pnas.0812261106
196. Scheuermann, S., Hambsch, B., Hesse, L., Stumm, J., Schmidt, C., Beher, D., et al. (2001). Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J. Biol. Chem. 276, 33923-33929. doi: 10.1074/jbc.M105410200
197. Schneider, A., Rajendran, L., Honsho, M., Gralle, M., Donnert, G., Wouters, F., et al. (2008). Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J. Neurosci. 28, 2874-2882. doi: 10.1523/JNEUROSCI.5345-07.2008
198. Schneider, A., Schulz-Schaeffer, W., Hartmann, T., Schulz, J. B., and Simons, M. (2006). Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons. Neurobiol. Dis. 23, 573-577. doi: 10.1016/j.nbd.2006.04.015
199. Schubert, D., and Chevion, M. (1995). The role of iron in beta amyloid toxicity. Biochem. Biophys. Res. Commun. 216, 702-707. doi: 10.1006/bbrc.1995.2678
200. Shankar, G. M., and Walsh, D. M. (2009). Alzheimer's disease: synaptic dysfunction and Abeta. Mol. Neurodegener. 4, 48. doi: 10.1186/1750-1326-4-48
201. Shearer, J., and Szalai, V. A. (2008). The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide. J. Am. Chem. Soc. 130, 17826-17835. doi: 10.1021/ja805940m
202. Shinall, H., Song, E. S., and Hersh, L. B. (2005). Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. Biochemistry 44, 15345-15350. doi: 10.1021/bi050650l
203. Shoji, M. (2002). Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness. Front. Biosci. 7:d997-d1006. doi: 10.2741/shoji
204. Simons, A., Ruppert, T., Schmidt, C., Schlicksupp, A., Pipkorn, R., Reed, J., et al. (2002). Evidence for a copper-binding superfamily of the amyloid precursor protein. Biochemistry 41, 9310-9320. doi: 10.1021/bi0258647
205. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., and Simons, K. (1998). Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 95, 6460-6464. doi: 10.1073/pnas.95.11.6460
206. Simons, M., Keller, P., Dichgans, J., and Schulz, J. B. (2001). Cholesterol and Alzheimer's disease: is there a link? Neurology 57, 1089-1093. doi: 10.1212/WNL.57.6.1089
207. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., et al. (1999). Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540. doi: 10.1038/990114
208. Smith, D. G., Ciccotosto, G. D., Tew, D. J., Perez, K., Curtain, C. C., Boas, J. F., et al. (2010). Histidine 14 modulates membrane binding and neurotoxicity of the Alzheimer's disease amyloid-beta peptide. J. Alzheimers Dis. 19, 1387-1400. doi: 10.3233/JAD-2010-1334
209. Smith, D. P., Smith, D. G., Curtain, C. C., Boas, J. F., Pilbrow, J. R., Ciccotosto, G. D., et al. (2006). Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge. J. Biol. Chem. 281, 15145-15154. doi: 10.1074/jbc.M600417200
210. Smith, M. A., Perry, G., Richey, P. L., Sayre, L. M., Anderson, V. E., Beal, M. F., et al. (1996). Oxidative damage in Alzheimer's. Nature 382, 120-121. doi: 10.1038/382120b0
211. Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., and Perry, G. (1997). Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 2653-2657.
212. Song, Y., Hustedt, E. J., Brandon, S., and Sanders, C. R. (2013). Competition between homodimerization and cholesterol binding to the C99 domain of the amyloid precursor protein. Biochemistry 52, 5051-5064. doi: 10.1021/bi400735x
213. Sparks, D. L., Petanceska, S., Sabbagh, M., Connor, D., Soares, H., Adler, C., et al. (2005). Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT). Curr. Alzheimer Res. 2, 527-539. doi: 10.2174/156720505774932296
214. Sparks, D. L., Scheff, S. W., Hunsaker, J. C. III, Liu, H., Landers, T., and Gross, D. R. (1994). Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126, 88-94. doi: 10.1006/exnr.1994.1044
215. Sparks, D. L., and Schreurs, B. G. (2003). Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 11065-11069. doi: 10.1073/pnas.1832769100
216. Spoerri, L., Vella, L. J., Pham, C. L., Barnham, K. J., and Cappai, R. (2012). The amyloid precursor protein copper binding domain histidine residues 149 and 151 mediate APP stability and metabolism. J. Biol. Chem. 287, 26840-26853. doi: 10.1074/jbc.M112.355743
217. Sponne, I., Fifre, A., Koziel, V., Oster, T., Olivier, J. L., and Pillot, T. (2004). Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide. FASEB J. 18, 836-838. doi: 10.1096/fj.03-0372fje
218. Stefani, M., and Liguri, G. (2009). Cholesterol in Alzheimer's disease: unresolved questions. Curr. Alzheimer Res. 6, 15-29. doi: 10.2174/156720509787313899
219. Stoltenberg, M., Bruhn, M., Sondergaard, C., Doering, P., West, M. J., Larsen, A., et al. (2005). Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques. Histochem. Cell Biol. 123, 605-611. doi: 10.1007/s00418-005-0787-0
220. Stoltenberg, M., Bush, A. I., Bach, G., Smidt, K., Larsen, A., Rungby, J., et al. (2007). Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Neuroscience 150, 357-369. doi: 10.1016/j.neuroscience.2007.09.025
221. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., et al. (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981. doi: 10.1073/pnas.90.5.1977
222. Suh, S. W., Jensen, K. B., Jensen, M. S., Silva, D. S., Kesslak, P. J., Danscher, G., et al. (2000). Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res. 852, 274-278. doi: 10.1016/S0006-8993(99)02096-X
223. Swaiman, K. F., and Machen, V. L. (1984). Iron uptake by mammalian cortical neurons. Ann. Neurol. 16, 66-70. doi: 10.1002/ana.410160113
224. Syme, C. D., Nadal, R. C., Rigby, S. E., and Viles, J. H. (2004). Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques. J. Biol. Chem. 279, 18169-18177. doi: 10.1074/jbc.M313572200
225. Syme, C. D., and Viles, J. H. (2006). Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease. Biochim. Biophys. Acta 1764, 246-256. doi: 10.1016/j.bbapap.2005.09.012
226. Tabner, B. J., Turnbull, S., El-Agnaf, O. M., and Allsop, D. (2002). Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radic. Biol. Med. 32, 1076-1083. doi: 10.1016/S0891-5849(02)00801-8
227. Tanzi, R. E., and Bertram, L. (2005). Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555. doi: 10.1016/j.cell.2005.02.008
228. Tougu, V., Karafin, A., and Palumaa, P. (2008). Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide. J. Neurochem. 104, 1249-1259. doi: 10.1111/j.1471-4159.2007.05061.x
229. Tougu, V., Karafin, A., Zovo, K., Chung, R. S., Howells, C., West, A. K., et al. (2009). Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J. Neurochem. 110, 1784-1795. doi: 10.1111/j.1471-4159.2009.06269.x
230. Valensin, D., Mancini, F. M., Luczkowski, M., Janicka, A., Wisniewska, K., Gaggelli, E., et al. (2004). Identification of a novel high affinity copper binding site in the APP(145-155) fragment of amyloid precursor protein. Dalton Trans. 16-22. doi: 10.1039/b312411h
231. Vance, J. E. (2006). Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett. 580, 5518-5524. doi: 10.1016/j.febslet.2006.06.008
232. Vanier, M. T., and Millat, G. (2003). Niemann-Pick disease type C. Clin. Genet. 64, 269-281. doi: 10.1034/j.1399-0004.2003.00147.x
233. Vanmierlo, T., Rutten, K., Dederen, J., Bloks, V. W., Van Vark-Van Der Zee, L. C., Kuipers, F., et al. (2011). Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol. Aging 32, 1262-1272. doi: 10.1016/j.neurobiolaging.2009.07.005
234. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., et al. (1999). Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741. doi: 10.1126/science.286.5440.735
235. Vekrellis, K., Ye, Z., Qiu, W. Q., Walsh, D., Hartley, D., Chesneau, V., et al. (2000). Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 20, 1657-1665.
236. Venti, A., Giordano, T., Eder, P., Bush, A. I., Lahiri, D. K., Greig, N. H., et al. (2004). The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region. Ann. N. Y. Acad. Sci. 1035, 34-48. doi: 10.1196/annals.1332.003
237. Vetrivel, K. S., Cheng, H., Lin, W., Sakurai, T., Li, T., Nukina, N., et al. (2004). Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem. 279, 44945-44954. doi: 10.1074/jbc.M407986200
238. Vigo-Pelfrey, C., Lee, D., Keim, P., Lieberburg, I., and Schenk, D. B. (1993). Characterization of beta-amyloid peptide from human cerebrospinal fluid. J. Neurochem. 61, 1965-1968. doi: 10.1111/j.1471-4159.1993.tb09841.x
239. Wahrle, S., Das, P., Nyborg, A. C., Mclendon, C., Shoji, M., Kawarabayashi, T., et al. (2002). Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9, 11-23. doi: 10.1006/nbdi.2001.0470
240. Wahrle, S. E., Jiang, H., Parsadanian, M., Hartman, R. E., Bales, K. R., Paul, S. M., et al. (2005). Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J. Biol. Chem. 280, 43236-43242. doi: 10.1074/jbc.M508780200
241. Wahrle, S. E., Jiang, H., Parsadanian, M., Kim, J., Li, A., Knoten, A., et al. (2008). Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J. Clin. Invest. 118, 671-682. doi: 10.1172/JCI33622
242. Wahrle, S. E., Jiang, H., Parsadanian, M., Legleiter, J., Han, X., Fryer, J. D., et al. (2004). ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J. Biol. Chem. 279, 40987-40993. doi: 10.1074/jbc.M407963200
243. Waldron, K. J., Rutherford, J. C., Ford, D., and Robinson, N. J. (2009). Metalloproteins and metal sensing. Nature 460, 823-830. doi: 10.1038/nature08300
244. Walkley, S. U., and Suzuki, K. (2004). Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim. Biophys. Acta 1685, 48-62. doi: 10.1016/j.bbalip.2004.08.011
245. Walter, J., Schindzielorz, A., Hartung, B., and Haass, C. (2000). Phosphorylation of the beta-amyloid precursor protein at the cell surface by ectocasein kinases 1 and 2. J. Biol. Chem. 275, 23523-23529. doi: 10.1074/jbc.M002850200
246. Wang, D. S., Iwata, N., Hama, E., Saido, T. C., and Dickson, D. W. (2003). Oxidized neprilysin in aging and Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 310, 236-241. doi: 10.1016/j.bbrc.2003.09.003
247. Wang, S. S., Rymer, D. L., and Good, T. A. (2001). Reduction in cholesterol and sialic acid content protects cells from the toxic effects of beta-amyloid peptides. J. Biol. Chem. 276, 42027-42034. doi: 10.1074/jbc.M102834200
248. Weidemann, A., Konig, G., Bunke, D., Fischer, P., Salbaum, J. M., Masters, C. L., et al. (1989). Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126. doi: 10.1016/0092-8674(89)90177-3
249. White, A. R., Multhaup, G., Maher, F., Bellingham, S., Camakaris, J., Zheng, H., et al. (1999a). The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J. Neurosci. 19, 9170-9179.
250. White, A. R., Reyes, R., Mercer, J. F., Camakaris, J., Zheng, H., Bush, A. I., et al. (1999b). Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 842, 439-444. doi: 10.1016/S0006-8993(99)01861-2
251. Whitehouse, P. J. (1997). Genesis of Alzheimer's disease. Neurology 48, S2-S7. doi: 10.1212/WNL.48.5_Suppl_7.2S
252. Wood, W. G., Schroeder, F., Avdulov, N. A., Chochina, S. V., and Igbavboa, U. (1999). Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease. Lipids 34, 225-234. doi: 10.1007/s11745-999-0357-9
253. Wu, W. H., Lei, P., Liu, Q., Hu, J., Gunn, A. P., Chen, M. S., et al. (2008). Sequestration of copper from beta-amyloid promotes selective lysis by cyclen-hybrid cleavage agents. J. Biol. Chem. 283, 31657-31664. doi: 10.1074/jbc.M804722200
254. Xu, X., and London, E. (2000). The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39, 843-849. doi: 10.1021/bi992543v
255. Yamauchi, K., Tozuka, M., Hidaka, H., Nakabayashi, T., Sugano, M., and Katsuyama, T. (2002). Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells. Ann. Clin. Lab. Sci. 32, 65-74.
256. Yamauchi, K., Tozuka, M., Hidaka, H., Nakabayashi, T., Sugano, M., Kondo, Y., et al. (2000). Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells. J. Neurosci. Res. 62, 608-614. doi: 10.1002/1097-4547(20001115)62:4< 608::AID-JNR16> 3.0.CO;2-4
257. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., et al. (1999). Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537. doi: 10.1038/990107
258. Yang, D. S., Small, D. H., Seydel, U., Smith, J. D., Hallmayer, J., Gandy, S. E., et al. (1999). Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience 90, 1217-1226. doi: 10.1016/S0306-4522(98)00561-2
259. Yip, C. M., Elton, E. A., Darabie, A. A., Morrison, M. R., and Mclaurin, J. (2001). Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J. Mol. Biol. 311, 723-734. doi: 10.1006/jmbi.2001.4881
260. You, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., et al. (2012). Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 109, 1737-1742. doi: 10.1073/pnas.1110789109 CrossRef Full Text Zampagni, M., Evangelisti, E., Cascella, R., Liguri, G., Becatti, M., Pensalfini, A., et al. (2010). Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane. J. Mol. Med. (Berl.) 88, 597-608. doi: 10.1007/s00109-010-0603-8
261. Zelcer, N., Khanlou, N., Clare, R., Jiang, Q., Reed-Geaghan, E. G., Landreth, G. E., et al. (2007). Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc. Natl. Acad. Sci. U.S.A. 104, 10601-10606. doi: 10.1073/pnas.0701096104
262. Zheng, H., and Koo, E. H. (2011). Biology and pathophysiology of the amyloid precursor protein. Mol. Neurodegener. 6, 27. doi: 10.1186/1750-1326-6-27
263. Zhou, Y., and Richardson, J. S. (1996). Cholesterol protects PC12 cells from beta-amyloid induced calcium disordering and cytotoxicity. Neuroreport 7, 2487-2490. doi: 10.1097/00001756-199611040-00017
264. Zlokovic, B. V. (2008). The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201. doi: 10.1016/j.neuron.2008.01.003